Characteristic,Number of drugs and vaccines
Preclinical,707
Phase I Clinical,98
Phase II Clinical,216
Phase III Clinical,104
Pre-registration,1
Registered,4
Launched,22
Discontinued,22
No development reported,51
Suspended,3
